Search
UK MHRA Guidance: Collection, Verification, and Reporting of Safety Events and Clinical Trials Regulations Transitional Arrangements
The UK clinical trials regulatory framework has undergone significant changes following amendments to the Medicines for Human Use (Clinical Trials) Regulations. These changes introduce updated requirements across clinical trial conduct, safety reporting, transparency, Good Clinical Practice (GCP), investigational medicinal products, and regulatory oversight. To support sponsors and investigators, the Medicines and Healthcare products Regulatory Agency (MHRA) has published upd
Sharan Murugan
Jul 184 min read